HR Execs on the Move

Novo Nordisk

www.novonordisk-us.com

 
Headquartered in Denmark, Novo Nordisk has more than 5,000 employees in the United States – representing 16% of the total workforce. From our insulin product manufacturing facility in Clayton, , North Carolina, to our Research and Development Center in Seattle, Washington we bring value to communities across the country in a variety of ways.   Our newly constructed LEED-certified building in Plainsboro, New Jersey, is modeled on principles of functionality, innovation, openness, quality, and aesthetics-offering a space that promotes collaboration and creativity.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Christopher Blanchette
 Vice President and Head, Clinical Development and Outcomes Research, NNI Profile
John McDonald
 Corporate Vice President, Global R&D Business Development Profile
Jill Branca Priselac
 VP, R&D Business Development Profile
Benjamin Soule
 Senior Medical Director, NASH - Clinical Development and Research, NNI Profile
Rahul Ganguly
 Vice President, Clinical Development & Outcomes Research Profile

Similar Companies

VDDI Pharmaceuticals

VDDI Pharmaceuticals is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Southmedic

Established in 1983 Southmedics Domestic Division is one of the largest independent distributors of operating room products in Canada with a dynamic and efficient sales force from coast to coast. We specialize in selling surgical and specialty operati...

Pharma Pac

Pharma Pac is a De Kalb, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Navidea

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics. Navidea is developing multiple precision-targeted products based on its Manocept™ platform to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Navidea`s Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. The Manocept platform serves as the molecular backbone of Tc99m tilmanocept, the first product developed and commercialized by Navidea based on the platform. Navidea`s strategy is to deliver superior growth and shareholder return by bringing to market novel products and advancing the Company`s pipeline through global partnering and commercialization efforts.

REDCON1

REDCON1 is a company that creates premium nutritional supplements for athletes of all levels, with the objective of bringing them to the highest state of readiness.